Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare

In this piece, we will look at the stocks Jim Cramer recently discussed.

In his recent appearance on CNBC’s Squawk on the Street, Jim Cramer started the morning by commenting on the S&P’s best eight-session rally since August. As most stock market gains by then had been due to mega-cap stocks, Cramer shared that “I do like to see that this is a rally that’s not led by” either Wall Street’s favorite AI GPU stock that tumbled by 15% on Monday or by the firm responsible for designing the iPhone.”

In fact, Cramer was happy that stocks were instead being led higher by sectors that had underperformed lately. One of these is healthcare, and the CNBC host shared his excitement by sharing “Or how about the drugs? How about the drugs!” He added “I mean last week I was at the JPMorgan Healthcare Conference. And no one liked the drugs! They exploded yesterday!”

Yet, even though the ‘drugs were exploding,’ Cramer also mentioned other sectors that were having bull markets. According to him “So what I’m saying is that, many bull markets each day. Banks had a bull market. Drugs had a bull market. Rails had a bull market. I think I love it! . . .This is what I want! Not broad on one day, but broad over time.”

As to the reason behind his optimism, Cramer outlined “I just don’t want it to be the same old, same old!” He was irate over market and media sentiment indicating that multiples of the Magnificent 7 stocks were overstretched. Mentioning a piece in the Financial Times, Cramer shared “Like yesterday there was a piece in the FT, I like the FT. But they were talking about how you know, now things are really stretched.” He believes that the argument that the multiples are overstretched doesn’t explain the S&P’s rally as  “It’s not a Mag 7 rally for heaven’s sake. It’s not!”

Cramer added, “Well I just think this is one of those markets where when you have a good quarter, bingo.” When co-host David Faber asked him why he believed that non-tech sectors were driving the market since technology stocks had done well until that point, Cramer replied and stated “I’m saying, this particular jaunt is not led by the usual suspects. I said all that stuff.” He added “But what I’m saying is that there are other stocks besides tech. That’s all I’m saying. And that yesterday was about healthcare. It was about healthcare and it hasn’t been about healthcare for a long time. The healthcare stocks, the HMOs were terrific.”

Another topic that he’s recently discussed is European stocks. When Cramer was asked why it’s not easy to find top-tier growth in Europe, he shared that “It is[n’t]. And yet, Europe is much discussed as being doing well because the rates are so low in Germany.”

Cramer also commented on the high power demand from AI data centers and how it’s affecting natural gas stocks. He believes “We have to spend, so much time on power, because we are beginning to get, what I’d be doing with these natural gas companies, they’re being green-lit, and they’re not being talked about, and they’re starting to realize, why is everything being nuclear?” The reason behind some folks doubting nuclear power, according to Cramer, is “Because nuclear is seven to eight years. Okay, seven to eight years.”

Our Methodology

To make our list of the stocks that Jim Cramer talked about, we listed down all the stocks he mentioned during CNBC’s Squawk on the Street aired on January 24th.

For these stocks, we also mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds invest in? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).

10. Skyworks Solutions, Inc. (NASDAQ:SWKS)

Number of Hedge Fund Holders In Q3 2024: 31

Skyworks Solutions, Inc. (NASDAQ:SWKS) is a semiconductor company that sells power management, signal processing, and other products to smartphones, auto, and other industries. Its shares are down by 15.4% over the past year as the firm has struggled to maintain revenue growth due to a slowdown in both of its targeted industries. Skyworks Solutions, Inc. (NASDAQ:SWKS)’s stock slumped by 18% in July and the first week of August after the firm’s profit dropped despite meeting analyst estimates. Cramer appreciated Skyworks Solutions, Inc. (NASDAQ:SWKS)’s management for being honest about its troubles:

“Let’s say you went to Liam Griffin, at Skyworks Solutions, he says listen, I can’t outrun cellphones. Not everybody sells into a data center! Not everyone sells into data center, and everybody seems to want nothing but. . . .”

9. Twilio Inc. (NYSE:TWLO)

Number of Hedge Fund Holders In Q3 2024: 52

Twilio Inc. (NYSE:TWLO) is a software company that provides products to businesses to enable them to communicate and stay in touch with their customers. While big tech roils in the aftermath of investor worries about China’s DeepSeek AI startup’s low model costs, Twilio Inc. (NYSE:TWLO) is one of the best-performing stocks year to date. Its shares are up by 27% so far this year primarily on the back of an optimistic margin guidance that predicted that margins will touch at least 21% in 2027. Margins are key for SaaS stocks such as Twilio Inc. (NYSE:TWLO), and here’s what Cramer said:

“[on TWLO saying they’ll meet the top end of their guidance] Yeah the customer relationship management product is really fabulous. They have expanded, they’ve done a great job. It’s a great product. Great product.”

8. Verizon Communications Inc. (NYSE:VZ)

Number of Hedge Fund Holders In Q3 2024: 57

Verizon Communications Inc. (NYSE:VZ) is one of the largest telecommunications companies in America. Its shares have lost 3.5% over the past year as a slow phone upgrade cycle due to inflation-constrained consumer spending and slow wireless equipment sales have led to the firm missing several quarterly earnings estimates. However, the tale turned in January when Verizon Communications Inc. (NYSE:VZ)’s shares jumped by 2.8% after the firm added 568,000 wireless subscribers in Q4 to beat analyst estimates of 487,500 and mark the highest quarterly growth in five years. Cramer, however, believes that the results were insufficient to drive the shares higher:

“[Commenting on Verizon stock jumping after earnings] On that number!”

7. Texas Instruments Incorporated (NASDAQ:TXN)

Number of Hedge Fund Holders In Q3 2024: 57

Texas Instruments Incorporated (NASDAQ:TXN) is one of the oldest chip manufacturing companies in America. Its shares are up by 12.6% over the past year as the firm’s broad product portfolio that enables data center connectivity has helped it navigate the downturn in the industrial sector. As of H1 2024, 76% of Texas Instruments Incorporated (NASDAQ:TXN)’s revenue came from industrial businesses. Consequently, the firm’s shares fell by 3.4% in January after its Q1 midpoint EPS guidance of $1.05 missed analyst estimates of $1.17. Cramer believes that Texas Instruments Incorporated (NASDAQ:TXN)’s exposure to industrial companies means that it should be viewed as an industrial stock:

“Right. People keep wanting Texas Instruments to be something other than it is. It’s an industrial company. Very good. 20% of business is in China by the way. Love the China. And uh why people think they can divorce themselves from the end market, particularly auto and industrial, crazy. You’re gonna have Joe Hinricks on, the CEO of CSX. You know he said, what’s weak? Automotives, uh, interest rate sensitive things, housing. Texas Instruments is an industrial company. And it trades like one. And these analysts keep thinking it’s going to trade like the Texas Instruments of 1982, 84. They ought to get the program. I think that Texas Instruments is very forthcoming. They used to be less forthcoming. But they’re basically saying, look, our markets aren’t that good. And they can’t outrun their own markets.

“I love the fact that they’re straight forward. That they’re not doing well in embedded, they’re saying, listen, we’re missing, we’re missing, we’re missing. People are missing. Enough already.”

6. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holders In Q3 2024: 61

Novo Nordisk A/S (NYSE:NVO) is one of the few companies in the world that has successfully made a splash with its weight loss drugs. Most of Cramer’s recent remarks for the firm have analyzed its product strength with respect to American weight loss drug giant Eli Lilly. Novo Nordisk A/S (NYSE:NVO)’s stock slipped by 17.8% in December after its weight loss drug trial missed investor expectations. They shed an additional 5.3% in January after its weight loss treatments were selected for Medicare price negotiations. Here’s what Cramer said about Novo Nordisk A/S (NYSE:NVO):

“[On the results of Novo’s latest drug trial] Okay, one and a half, it’s early. Remember it’s a one half trial. Now, you cane make these, you can finagle Lilly versus Novo. It’s hard, very hard to do actual comparisons because some are by forty eight weeks, some are shorter weeks. Some are bigger. . . what really matters? Boom, Eli Lilly’s scripts are way up. And if you’re looking at the fourth quarter, remember fourth quarter was a disappointment. David Ricks came on Mad Money, he came on our show. What did he say? He said we botched the launch. This is the beginning. Wolfe puts out the scripts, the numbers for Lilly were really good. And that’s what I’ve been waiting for. We can do this head to head of the phase one, the half. Forget that. Novo’s down so much, anything they put out . . .and this thing causes, you know it like makes you feel better. It wouldn’t matter. What matters is that Mounjaro and Zepbound weekly scripts are finally, finally doing good. And they have been not good. . . .”

“Lilly versus Novo this morning. Not one. Looked at every single data test that there is. Not one.”

5. Cheniere Energy, Inc. (NYSE:LNG)

Number of Hedge Fund Holders In Q3 2024: 62

Cheniere Energy, Inc. (NYSE:LNG) is an American energy company that operates primarily in the midstream portion of the liquefied natural gas (LNG) supply chain. Its shares are up by 35% over the past year as the firm benefited from higher Asian LNG prices and an 11.6% share price surge after the November Presidential Election. Cheniere Energy, Inc. (NYSE:LNG)’s shares are up by 1.80% year-to-date as well due to rising LNG demand in America which surged to a record 15.2 billion cubic feet per day as 2024 ended. Here’s what Cramer said about Cheniere Energy, Inc. (NYSE:LNG):

“Cheniere’s been an unbelievable story. I remember when Cheniere was at two bucks. I mean cause what happened is this that we ended up having reverse all the pipes when Cheniere started natural gas we were importing. Then it turned to an export. Look they’re not making, they have revenue, revenue downstream.

“Well if you wanna play on what the President is saying about how we can weaponize it, weaponize the natural gas, this is it.”

4. American Express Company (NYSE:AXP)

Number of Hedge Fund Holders In Q3 2024: 62

American Express Company (NYSE:AXP) is one of the most well-known financial services firms in America. The firm is one of the earliest movers in the payment card industry. Its shares are up by 57% over the past year as American Express Company (NYSE:AXP) managed to beat multiple quarterly estimates in 2024 either through higher spending on its platforms or through financial discipline. In 2025, its shares are up by 5.7% after having dropped by 3.2% since its Q4 earnings report. The results saw American Express Company (NYSE:AXP) guide 2025 revenue growth at a 9% midpoint which appeared to be a tepid beat over analysts’ 8.1% estimate. Cramer, however, gushed about the stock:

“What I think that’s most impressive about Amex, and I think that would really perplex Jay Powell, this spend is insane in this country. The amount of people traveling. The bump up to first class, from commercial, from the, you know what second class we’ll call it, David.  Uh, the amount of people just, the frequency at which people are having a dinner out. I don’t know what to say, there’s a burst of optimism that is being translated into spend. And particularly for younger people that I’m just flabbergasted about. It just can’t stop!

“[on whether the high spending was leading to the stock’s strong performance] Well I think that this is the last poor quarter, and I talked to Steve Squeri, this keeps happening. The stock goes up huge ahead. I mean there’s one of the greatest charts of all time. And then people say oh it wasn’t, you know eight to ten, it gave to eight to ten, so it didn’t blow things away. I mean this guy is delivering a level of consistency that is so much better than everybody else. You could take all those fintech stories and this is just the best one. . . . .But American Express, no flies, good quarter, Steve Squeri doing a terrific job, at one point the stock was down twelve. I don’t know who does this, uh ahead of the quarter, but when I speak to them I just think, just wow and their customers love it.”

3. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders In Q3 2024: 63

Abbott Laboratories (NYSE:ABT) is a healthcare giant that ended 2024 on a tepid note. Its shares gained a modest 3.8% during the year as the firm battled the fallout from its infant formula lawsuit through mostly strong earnings reports because of its medical devices business. Like other mega American healthcare companies, Abbott Laboratories (NYSE:ABT) is facing tightness in China. However, in his previous remarks, Cramer has been optimistic about the firm’s diabetes portfolio which includes glucose monitoring devices. The optimism was warranted as Abbott Laboratories (NYSE:ABT)’s shares have gained 10% since its Q4 earnings came with a midpoint 2025 profit per share guidance of $5.15 which was in line with estimates. Cramer was surprised about Abbott Laboratories (NYSE:ABT)’s share surge:

“Abbot Labs was the market leader yesterday. That’s new. That’s new.”

2. Capital One Financial Corporation (NYSE:COF)

Number of Hedge Fund Holders In Q3 2024: 67

Capital One Financial Corporation (NYSE:COF) is an American consumer and commercial bank headquartered in McLean, Virginia. Like other bank stocks, the shares have been on a tear since the November US Presidential Election. Since the election, Capital One Financial Corporation (NYSE:COF)’s shares have gained 25%. The stock has been helped by the fact that consumer spending has remained robust in America to allow it to earn income through interest via credit card debt. Capital One Financial Corporation (NYSE:COF) has sizable exposure to credit card spending, and according to Cramer, its merger with Discover can further improve prospects:

“By the way Capital One when they merge with Discover is going to be really really fabulous and we’re working a lot on that one.”

1. Union Pacific Corporation (NYSE:UNP)

Number of Hedge Fund Holders In Q3 2024: 78

Union Pacific Corporation (NYSE:UNP) is one of the largest railroad operators in America. Since it primarily transports industrial raw materials and bulk goods all over the US, the stock is dependent on economic activity. Union Pacific Corporation (NYSE:UNP)’s shares jumped by 5% in January after its Q4 results revealed a $2.96 profit per share that beat analyst estimates of $2.78. Following the report, Cramer was full of praise for the company. He commented that Union Pacific Corporation (NYSE:UNP)’s operating ratio was “superb” and added that not only can it benefit from stronger pricing but also from a potential boom in coal demand in America. This time around, he compared Union Pacific Corporation (NYSE:UNP) with another railroad firm, CSX:

“But, you’ll see these beautiful one-off moves. Union Pacific great quarter versus CSX.”

UNP is a stock Jim Cramer recently talked about. While we acknowledge the potential of UNP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than UNP but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.